Translational Development Acquisition Corp. (TDACW) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
TDACW EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TDACW Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
Download Data
Export TDACW earnings history in CSV or JSON format
Free sign-in required to download data
Translational Development Acquisition Corp. (TDACW) Earnings Overview
As of May 8, 2026, Translational Development Acquisition Corp. (TDACW) reported trailing twelve-month net income of $5M, reflecting -5416.7% year-over-year growth. The company earned $0.28 per diluted share over the past four quarters.
Looking at the long-term picture, TDACW's historical earnings data spans multiple years. The company achieved its highest annual net income of $3M in fiscal 2019.
Translational Development Acquisition Corp. maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including BRTX (-$13M net income, -2239.2% margin), HCAI (N/A net income, 3.7% margin), IQV ($1.39B net income, 8.3% margin), TDACW has comparable earnings metrics. Compare TDACW vs BRTX →
TDACW Earnings vs Peers
Earnings metrics vs comparable public companies
TDACW Historical Earnings Data (2017–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $-71,012 | +85.4% | $-196,358 | $-3.31 | - | - |
| 2023 | $-485,550 | -930.7% | $-485,550 | $-0.06 | - | - |
| 2022 | $-47,108 | +96.2% | $-47,108 | $-0.00 | - | - |
| 2020 | -$1M | -149.1% | -$1M | $-0.17 | - | - |
| 2019 | $3M | +80.4% | -$1M | $0.36 | - | - |
| 2018 | $1M | +362912.1% | $-699,334 | $0.24 | - | - |
| 2017 | $-387 | - | $-387 | $-0.00 | - | - |
See TDACW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TDACW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TDACW vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonTDACW — Frequently Asked Questions
Quick answers to the most common questions about buying TDACW stock.
Is TDACW growing earnings?
TDACW EPS fell to $0.28, with earnings declining -5416.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $5M.
What are TDACW's profit margins?
Translational Development Acquisition Corp. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are TDACW's earnings?
TDACW earnings data spans 2017-2024. The declining earnings trend is -5416.7% YoY. Historical data enables comparison across business cycles.